Eric Schmidt Stock Analyst Profile - Cantor Fitzgerald Research Coverage - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Eric Schmidt

    Stock Analyst at Cantor Fitzgerald

    (3.7)
    # 2364
    Out of 5,506 analysts
    56
    Total ratings
    Success rate
    Average return
    Main Sectors:
    Healthcare
    Top Industries:
    Biotechnology Drug Manufacturers - General

    23 Stocks

    Name Action PT Current % Upside Ratings Updated
    SMMT Summit Therapeutics
    Reiterates: Overweight
    n/a
    		n/a n/a 3 Sep 8, 2025
    LEGN Legend Biotech
    Assumes: Overweight
    55 66
    		32.06 105.86% 1 Aug 27, 2025
    SRRK Scholar Rock Holding
    Initiates Coverage On: Overweight
    n/a
    		n/a n/a 1 Jul 17, 2025
    RNA Avidity Biosciences
    Reiterates: Overweight
    96 96
    		46.97 104.39% 5 Jun 27, 2025
    PRTA Prothena Corp
    Reiterates: Neutral
    n/a
    		n/a n/a 2 Jun 20, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Overweight
    n/a
    		n/a n/a 2 Jun 10, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Overweight
    n/a
    		n/a n/a 4 Apr 1, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Overweight
    n/a
    		n/a n/a 1 Mar 21, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Overweight
    n/a
    		n/a n/a 4 Mar 20, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Overweight
    14 14
    		17.04 -23.65% 2 Mar 13, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Overweight
    n/a
    		n/a n/a 2 Mar 7, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Neutral
    n/a
    		n/a n/a 4 Feb 19, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Neutral
    n/a
    		n/a n/a 6 Jan 10, 2025
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Overweight
    n/a
    		n/a n/a 4 Dec 18, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Overweight
    n/a
    		n/a n/a 3 Dec 5, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Neutral
    n/a
    		n/a n/a 2 Sep 16, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Overweight
    n/a
    		n/a n/a 2 Sep 9, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Overweight
    292 292
    		159.88 82.64% 3 Sep 9, 2024
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Reiterates: Overweight
    370
    		403.12 -8.22% 1 Oct 17, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Downgrades: Neutral
    n/a
    		n/a n/a 1 Oct 17, 2023
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Upgrades: Outperform
    n/a
    		n/a n/a 1 Jul 10, 2017
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Outperform
    31
    		n/a n/a 1 Jun 12, 2017
    XXXX
    XXXXXXXXXXXXXXXX
    Upgrade
    Initiates Coverage On: Outperform
    n/a
    		n/a n/a 1 May 30, 2017